世界の増殖糖尿病網膜症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Proliferative Diabetic Retinopathy Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4768 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、増殖糖尿病網膜症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オクリプラスミン、PAN-90806、RBM-008、乳酸スクアラミン、THR-687、その他）、用途別市場規模（病院、クリニック、在宅医療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・増殖糖尿病網膜症治療薬の市場動向 ・企業の競争状況、市場シェア ・増殖糖尿病網膜症治療薬の種類別市場規模と予測2016-2027（オクリプラスミン、PAN-90806、RBM-008、乳酸スクアラミン、THR-687、その他） ・増殖糖尿病網膜症治療薬の用途別市場規模と予測2016-2027（病院、クリニック、在宅医療） ・増殖糖尿病網膜症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・増殖糖尿病網膜症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・増殖糖尿病網膜症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・増殖糖尿病網膜症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・増殖糖尿病網膜症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Acucela Inc、Aerie Pharmaceuticals Inc、Antisense Therapeutics Ltd、Icon Bioscience Inc、Ohr Pharmaceutical Inc、PanOptica Inc、Ribomic Inc、ThromboGenics NV） ・結論

Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market
The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Proliferative Diabetic Retinopathy Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Proliferative Diabetic Retinopathy Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Proliferative Diabetic Retinopathy Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Proliferative Diabetic Retinopathy Therapeutics market.

Global Proliferative Diabetic Retinopathy Therapeutics Scope and Market Size
Proliferative Diabetic Retinopathy Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Proliferative Diabetic Retinopathy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ocriplasmin
PAN-90806
RBM-008
Squalamine Lactate
THR-687
Others

Segment by Application
Hospital
Clinic
Home Care

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Acucela Inc
Aerie Pharmaceuticals Inc
Antisense Therapeutics Ltd
Icon Bioscience Inc
Ohr Pharmaceutical Inc
PanOptica Inc
Ribomic Inc
ThromboGenics NV

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ocriplasmin
1.2.3 PAN-90806
1.2.4 RBM-008
1.2.5 Squalamine Lactate
1.2.6 THR-687
1.2.7 Others
1.3 Market by Application
1.3.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Perspective (2016-2027)
2.2 Proliferative Diabetic Retinopathy Therapeutics Growth Trends by Regions
2.2.1 Proliferative Diabetic Retinopathy Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Proliferative Diabetic Retinopathy Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Proliferative Diabetic Retinopathy Therapeutics Industry Dynamic
2.3.1 Proliferative Diabetic Retinopathy Therapeutics Market Trends
2.3.2 Proliferative Diabetic Retinopathy Therapeutics Market Drivers
2.3.3 Proliferative Diabetic Retinopathy Therapeutics Market Challenges
2.3.4 Proliferative Diabetic Retinopathy Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Revenue
3.1.1 Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Proliferative Diabetic Retinopathy Therapeutics Revenue
3.4 Global Proliferative Diabetic Retinopathy Therapeutics Market Concentration Ratio
3.4.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Proliferative Diabetic Retinopathy Therapeutics Revenue in 2020
3.5 Proliferative Diabetic Retinopathy Therapeutics Key Players Head office and Area Served
3.6 Key Players Proliferative Diabetic Retinopathy Therapeutics Product Solution and Service
3.7 Date of Enter into Proliferative Diabetic Retinopathy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Proliferative Diabetic Retinopathy Therapeutics Breakdown Data by Type
4.1 Global Proliferative Diabetic Retinopathy Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Type (2022-2027)

5 Proliferative Diabetic Retinopathy Therapeutics Breakdown Data by Application
5.1 Global Proliferative Diabetic Retinopathy Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size (2016-2027)
6.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type
6.2.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2027)
6.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application
6.3.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2027)
6.4 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country
6.4.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size (2016-2027)
7.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type
7.2.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2027)
7.3 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application
7.3.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2027)
7.4 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country
7.4.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type
8.2.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application
8.3.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region
8.4.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size (2016-2027)
9.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type
9.2.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application
9.3.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country
9.4.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type
10.2.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application
10.3.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country
10.4.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Acucela Inc
11.1.1 Acucela Inc Company Details
11.1.2 Acucela Inc Business Overview
11.1.3 Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Introduction
11.1.4 Acucela Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
11.1.5 Acucela Inc Recent Development
11.2 Aerie Pharmaceuticals Inc
11.2.1 Aerie Pharmaceuticals Inc Company Details
11.2.2 Aerie Pharmaceuticals Inc Business Overview
11.2.3 Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Introduction
11.2.4 Aerie Pharmaceuticals Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
11.2.5 Aerie Pharmaceuticals Inc Recent Development
11.3 Antisense Therapeutics Ltd
11.3.1 Antisense Therapeutics Ltd Company Details
11.3.2 Antisense Therapeutics Ltd Business Overview
11.3.3 Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Introduction
11.3.4 Antisense Therapeutics Ltd Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
11.3.5 Antisense Therapeutics Ltd Recent Development
11.4 Icon Bioscience Inc
11.4.1 Icon Bioscience Inc Company Details
11.4.2 Icon Bioscience Inc Business Overview
11.4.3 Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Introduction
11.4.4 Icon Bioscience Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
11.4.5 Icon Bioscience Inc Recent Development
11.5 Ohr Pharmaceutical Inc
11.5.1 Ohr Pharmaceutical Inc Company Details
11.5.2 Ohr Pharmaceutical Inc Business Overview
11.5.3 Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Introduction
11.5.4 Ohr Pharmaceutical Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
11.5.5 Ohr Pharmaceutical Inc Recent Development
11.6 PanOptica Inc
11.6.1 PanOptica Inc Company Details
11.6.2 PanOptica Inc Business Overview
11.6.3 PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Introduction
11.6.4 PanOptica Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
11.6.5 PanOptica Inc Recent Development
11.7 Ribomic Inc
11.7.1 Ribomic Inc Company Details
11.7.2 Ribomic Inc Business Overview
11.7.3 Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Introduction
11.7.4 Ribomic Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
11.7.5 Ribomic Inc Recent Development
11.8 ThromboGenics NV
11.8.1 ThromboGenics NV Company Details
11.8.2 ThromboGenics NV Business Overview
11.8.3 ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Introduction
11.8.4 ThromboGenics NV Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
11.8.5 ThromboGenics NV Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ocriplasmin
Table 3. Key Players of PAN-90806
Table 4. Key Players of RBM-008
Table 5. Key Players of Squalamine Lactate
Table 6. Key Players of THR-687
Table 7. Key Players of Others
Table 8. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Regions (2022-2027)
Table 14. Proliferative Diabetic Retinopathy Therapeutics Market Trends
Table 15. Proliferative Diabetic Retinopathy Therapeutics Market Drivers
Table 16. Proliferative Diabetic Retinopathy Therapeutics Market Challenges
Table 17. Proliferative Diabetic Retinopathy Therapeutics Market Restraints
Table 18. Global Proliferative Diabetic Retinopathy Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proliferative Diabetic Retinopathy Therapeutics as of 2020)
Table 21. Ranking of Global Top Proliferative Diabetic Retinopathy Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Proliferative Diabetic Retinopathy Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Proliferative Diabetic Retinopathy Therapeutics Product Solution and Service
Table 25. Date of Enter into Proliferative Diabetic Retinopathy Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Acucela Inc Company Details
Table 66. Acucela Inc Business Overview
Table 67. Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Product
Table 68. Acucela Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Acucela Inc Recent Development
Table 70. Aerie Pharmaceuticals Inc Company Details
Table 71. Aerie Pharmaceuticals Inc Business Overview
Table 72. Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Product
Table 73. Aerie Pharmaceuticals Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Aerie Pharmaceuticals Inc Recent Development
Table 75. Antisense Therapeutics Ltd Company Details
Table 76. Antisense Therapeutics Ltd Business Overview
Table 77. Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Product
Table 78. Antisense Therapeutics Ltd Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Antisense Therapeutics Ltd Recent Development
Table 80. Icon Bioscience Inc Company Details
Table 81. Icon Bioscience Inc Business Overview
Table 82. Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Product
Table 83. Icon Bioscience Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Icon Bioscience Inc Recent Development
Table 85. Ohr Pharmaceutical Inc Company Details
Table 86. Ohr Pharmaceutical Inc Business Overview
Table 87. Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Product
Table 88. Ohr Pharmaceutical Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Ohr Pharmaceutical Inc Recent Development
Table 90. PanOptica Inc Company Details
Table 91. PanOptica Inc Business Overview
Table 92. PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Product
Table 93. PanOptica Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 94. PanOptica Inc Recent Development
Table 95. Ribomic Inc Company Details
Table 96. Ribomic Inc Business Overview
Table 97. Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Product
Table 98. Ribomic Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Ribomic Inc Recent Development
Table 100. ThromboGenics NV Company Details
Table 101. ThromboGenics NV Business Overview
Table 102. ThromboGenics NV Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 103. ThromboGenics NV Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Ocriplasmin Features
Figure 3. PAN-90806 Features
Figure 4. RBM-008 Features
Figure 5. Squalamine Lactate Features
Figure 6. THR-687 Features
Figure 7. Others Features
Figure 8. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Home Care Case Studies
Figure 12. Proliferative Diabetic Retinopathy Therapeutics Report Years Considered
Figure 13. Global Proliferative Diabetic Retinopathy Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Proliferative Diabetic Retinopathy Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Players in 2020
Figure 18. Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proliferative Diabetic Retinopathy Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Proliferative Diabetic Retinopathy Therapeutics Revenue in 2020
Figure 20. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Proliferative Diabetic Retinopathy Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Proliferative Diabetic Retinopathy Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Share by Region (2016-2027)
Figure 42. China Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Acucela Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
Figure 62. Aerie Pharmaceuticals Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
Figure 63. Antisense Therapeutics Ltd Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
Figure 64. Icon Bioscience Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
Figure 65. Ohr Pharmaceutical Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
Figure 66. PanOptica Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
Figure 67. Ribomic Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
Figure 68. ThromboGenics NV Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---